| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 7.69e-06 | 14 | 192 | 4 | GO:0005130 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 1.73e-05 | 34 | 192 | 5 | GO:0015125 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 5.75e-05 | 70 | 192 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 6.36e-05 | 23 | 192 | 4 | GO:0034235 | |
| GeneOntologyMolecularFunction | filamin binding | 1.63e-04 | 29 | 192 | 4 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 1.63e-04 | 29 | 192 | 4 | GO:0035325 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 1.81e-04 | 12 | 192 | 3 | GO:0005436 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 2.76e-04 | 173 | 192 | 8 | GO:0070851 | |
| GeneOntologyMolecularFunction | flavin adenine dinucleotide binding | 2.95e-04 | 94 | 192 | 6 | GO:0050660 | |
| GeneOntologyMolecularFunction | microtubule minus-end binding | 3.66e-04 | 15 | 192 | 3 | GO:0051011 | |
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.27e-04 | 37 | 192 | 4 | GO:0140658 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 6.06e-04 | 149 | 192 | 7 | GO:1990782 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 6.90e-04 | 73 | 192 | 5 | GO:0170055 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 1.00e-03 | 316 | 192 | 10 | GO:0035091 | |
| GeneOntologyMolecularFunction | glycolipid binding | 1.25e-03 | 49 | 192 | 4 | GO:0051861 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.44e-03 | 127 | 192 | 6 | GO:0008094 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 1.53e-03 | 24 | 192 | 3 | GO:0005315 | |
| GeneOntologyMolecularFunction | ATPase-coupled ion transmembrane transporter activity | 1.53e-03 | 24 | 192 | 3 | GO:0042625 | |
| GeneOntologyMolecularFunction | ATPase activity, coupled to transmembrane movement of ions, rotational mechanism | 1.53e-03 | 24 | 192 | 3 | GO:0044769 | |
| GeneOntologyMolecularFunction | proton-transporting ATPase activity, rotational mechanism | 1.53e-03 | 24 | 192 | 3 | GO:0046961 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 9.66e-07 | 20 | 194 | 5 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 7.06e-06 | 14 | 194 | 4 | GO:0070348 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 9.55e-06 | 15 | 194 | 4 | GO:0070347 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 9.55e-06 | 15 | 194 | 4 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 9.55e-06 | 15 | 194 | 4 | GO:0002859 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 9.55e-06 | 15 | 194 | 4 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 1.26e-05 | 16 | 194 | 4 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 1.64e-05 | 17 | 194 | 4 | GO:0070342 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 1.64e-05 | 17 | 194 | 4 | GO:1901143 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 1.64e-05 | 17 | 194 | 4 | GO:0038158 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 2.09e-05 | 18 | 194 | 4 | GO:1903385 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 2.10e-05 | 60 | 194 | 6 | GO:0030851 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 2.73e-05 | 38 | 194 | 5 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 4.01e-05 | 21 | 194 | 4 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 4.01e-05 | 21 | 194 | 4 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 4.01e-05 | 21 | 194 | 4 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 4.86e-05 | 22 | 194 | 4 | GO:0030853 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 5.84e-05 | 23 | 194 | 4 | GO:0002858 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 5.84e-05 | 23 | 194 | 4 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 6.96e-05 | 24 | 194 | 4 | GO:0002855 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 6.96e-05 | 24 | 194 | 4 | GO:2001214 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 6.96e-05 | 24 | 194 | 4 | GO:0002420 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 7.01e-05 | 46 | 194 | 5 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 7.01e-05 | 46 | 194 | 5 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 7.78e-05 | 47 | 194 | 5 | GO:0015721 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 8.22e-05 | 25 | 194 | 4 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 8.22e-05 | 25 | 194 | 4 | GO:0002423 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 9.53e-05 | 49 | 194 | 5 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.12e-04 | 27 | 194 | 4 | GO:0070344 | |
| GeneOntologyBiologicalProcess | cell-cell junction organization | PSG4 PSG9 CDHR3 CEACAM6 PSG8 NPHS1 CNTNAP1 CLDN9 EFNB2 XIRP2 | 1.17e-04 | 246 | 194 | 10 | GO:0045216 |
| GeneOntologyBiologicalProcess | MDA-5 signaling pathway | 1.28e-04 | 11 | 194 | 3 | GO:0039530 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.30e-04 | 28 | 194 | 4 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.50e-04 | 29 | 194 | 4 | GO:2001212 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | PSG4 PSG9 CDHR3 CEACAM6 NRXN1 PSG8 NRCAM PCDHB8 CLDN9 HMCN1 IL1RAP | 1.94e-04 | 313 | 194 | 11 | GO:0098742 |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 1.96e-04 | 31 | 194 | 4 | GO:0010544 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 2.22e-04 | 32 | 194 | 4 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 2.22e-04 | 32 | 194 | 4 | GO:0045779 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 2.22e-04 | 32 | 194 | 4 | GO:0060312 | |
| GeneOntologyBiologicalProcess | positive regulation of MAP kinase activity | 2.22e-04 | 129 | 194 | 7 | GO:0043406 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 2.32e-04 | 59 | 194 | 5 | GO:0045671 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 2.51e-04 | 33 | 194 | 4 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 2.51e-04 | 33 | 194 | 4 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 2.82e-04 | 34 | 194 | 4 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 2.82e-04 | 34 | 194 | 4 | GO:0046851 | |
| GeneOntologyBiologicalProcess | regulation of ERK1 and ERK2 cascade | PDGFRB PSG4 PSG9 CEACAM6 NRXN1 PSG8 DMD NOX4 GPR183 THPO IL1A FBXW7 | 3.01e-04 | 385 | 194 | 12 | GO:0070372 |
| GeneOntologyBiologicalProcess | insulin metabolic process | 3.16e-04 | 35 | 194 | 4 | GO:1901142 | |
| GeneOntologyBiologicalProcess | receptor internalization | 3.36e-04 | 182 | 194 | 8 | GO:0031623 | |
| GeneOntologyBiologicalProcess | regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction | PDGFRB PSG4 PSG9 UNC5B CEACAM6 TYRO3 NRXN1 PSG8 FGR NOX4 THPO | 3.38e-04 | 334 | 194 | 11 | GO:0051896 |
| GeneOntologyBiologicalProcess | bone resorption | 3.48e-04 | 99 | 194 | 6 | GO:0045453 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 4.03e-04 | 187 | 194 | 8 | GO:0007156 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | PDGFRB PSG4 PSG9 CEACAM6 TYRO3 NRXN1 PSG8 FGD2 NOX4 ALS2 NEURL1 FBXW7 | 4.74e-04 | 405 | 194 | 12 | GO:0033674 |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 4.82e-04 | 39 | 194 | 4 | GO:0045717 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 4.97e-04 | 193 | 194 | 8 | GO:0071902 | |
| GeneOntologyBiologicalProcess | positive regulation of protein kinase activity | PDGFRB PSG4 PSG9 CEACAM6 NRXN1 PSG8 FGD2 NOX4 ALS2 NEURL1 FBXW7 | 5.00e-04 | 350 | 194 | 11 | GO:0045860 |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 5.16e-04 | 70 | 194 | 5 | GO:0045124 | |
| GeneOntologyBiologicalProcess | endoplasmic reticulum tubular network membrane organization | 5.22e-04 | 4 | 194 | 2 | GO:1990809 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 5.32e-04 | 40 | 194 | 4 | GO:0045953 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 5.51e-04 | 71 | 194 | 5 | GO:0043114 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 5.85e-04 | 41 | 194 | 4 | GO:0002716 | |
| GeneOntologyBiologicalProcess | presynapse organization | 6.26e-04 | 73 | 194 | 5 | GO:0099172 | |
| GeneOntologyBiologicalProcess | ERK1 and ERK2 cascade | PDGFRB PSG4 PSG9 CEACAM6 NRXN1 PSG8 DMD NOX4 GPR183 THPO IL1A FBXW7 | 6.26e-04 | 418 | 194 | 12 | GO:0070371 |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 6.42e-04 | 42 | 194 | 4 | GO:0090330 | |
| GeneOntologyBiologicalProcess | regulation of growth hormone secretion | 7.10e-04 | 19 | 194 | 3 | GO:0060123 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 7.37e-04 | 114 | 194 | 6 | GO:0045824 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 7.52e-04 | 76 | 194 | 5 | GO:0042269 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte differentiation | PSG4 PSG9 IL17C CEACAM6 STAT5A PSG8 GPR183 BATF2 MFSD8 FBXW7 | 7.72e-04 | 312 | 194 | 10 | GO:0002573 |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 8.36e-04 | 45 | 194 | 4 | GO:0048521 | |
| GeneOntologyBiologicalProcess | positive regulation of epidermal growth factor-activated receptor activity | 8.64e-04 | 5 | 194 | 2 | GO:0045741 | |
| GeneOntologyBiologicalProcess | tissue remodeling | 8.68e-04 | 262 | 194 | 9 | GO:0048771 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 8.83e-04 | 118 | 194 | 6 | GO:0001570 | |
| GeneOntologyBiologicalProcess | cell junction organization | PSG4 PSG9 CDHR3 CEACAM6 NRXN1 PSG8 NPHS1 NRCAM CNTNAP1 PCDHB8 ALS2 CLDN9 EFNB2 XIRP2 NEURL1 LRP4 MACF1 RIMS2 IL1RAP CACNA2D3 | 8.92e-04 | 974 | 194 | 20 | GO:0034330 |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 9.50e-04 | 80 | 194 | 5 | GO:0002715 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 9.50e-04 | 80 | 194 | 5 | GO:0046850 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 9.87e-04 | 47 | 194 | 4 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 9.87e-04 | 47 | 194 | 4 | GO:0034104 | |
| GeneOntologyBiologicalProcess | phosphatidylinositol 3-kinase/protein kinase B signal transduction | PDGFRB PSG4 PSG9 UNC5B CEACAM6 TYRO3 NRXN1 PSG8 FGR NOX4 THPO | 1.02e-03 | 382 | 194 | 11 | GO:0043491 |
| GeneOntologyBiologicalProcess | positive regulation of MAPK cascade | PDGFRB PSG4 PSG9 CEACAM6 NRXN1 PSG8 NMNAT1 FGD2 NOX4 GPR183 CCDC88C THPO IL1A FBXW7 | 1.06e-03 | 571 | 194 | 14 | GO:0043410 |
| GeneOntologyBiologicalProcess | growth hormone secretion | 1.11e-03 | 22 | 194 | 3 | GO:0030252 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 1.15e-03 | 49 | 194 | 4 | GO:0002837 | |
| GeneOntologyBiologicalProcess | cytokine-mediated signaling pathway | IL16 PSG4 PSG9 CEACAM6 STAT5A PSG8 TUT4 OAS3 IFNGR1 THPO IL1A IL1RAP IL5RA CXCR2 | 1.17e-03 | 577 | 194 | 14 | GO:0019221 |
| GeneOntologyBiologicalProcess | regulation of leukocyte proliferation | 1.24e-03 | 332 | 194 | 10 | GO:0070663 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 1.25e-03 | 50 | 194 | 4 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 1.25e-03 | 85 | 194 | 5 | GO:0002762 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 1.20e-05 | 16 | 194 | 4 | GO:0070021 | |
| GeneOntologyCellularComponent | microtubule minus-end | 2.68e-05 | 7 | 194 | 3 | GO:0036449 | |
| GeneOntologyCellularComponent | anchoring junction | IL16 EPPK1 PDGFRB PSG4 PSG9 CDHR3 PAK4 CEACAM6 SENP1 NRXN1 SVIL PSG8 DMD NPHS1 CNTNAP1 NOX4 CLDN9 CCDC88C EFNB2 HMCN1 XIRP2 | 3.02e-04 | 976 | 194 | 21 | GO:0070161 |
| Domain | ig | A1BG PDGFRB PSG4 PSG7 PSG9 CEACAM6 PTGFRN TYRO3 PSG8 NPHS1 NRCAM HMCN1 IGSF1 | 6.34e-08 | 190 | 187 | 13 | PF00047 |
| Domain | Immunoglobulin | A1BG PDGFRB PSG4 PSG7 PSG9 CEACAM6 PTGFRN TYRO3 PSG8 NPHS1 NRCAM HMCN1 IGSF1 | 6.34e-08 | 190 | 187 | 13 | IPR013151 |
| Domain | IGc2 | A1BG PDGFRB PSG4 PSG7 PSG9 UNC5B CEACAM6 IGSF10 TYRO3 PSG8 NPHS1 NRCAM HMCN1 IGSF1 | 1.10e-07 | 235 | 187 | 14 | SM00408 |
| Domain | Ig_sub2 | A1BG PDGFRB PSG4 PSG7 PSG9 UNC5B CEACAM6 IGSF10 TYRO3 PSG8 NPHS1 NRCAM HMCN1 IGSF1 | 1.10e-07 | 235 | 187 | 14 | IPR003598 |
| Domain | IG | A1BG PDGFRB PSG4 PSG7 PSG9 UNC5B CEACAM6 PTGFRN IGSF10 TYRO3 PSG8 NPHS1 NRCAM HMCN1 IGSF1 IL1RAP | 5.48e-06 | 421 | 187 | 16 | SM00409 |
| Domain | Ig_sub | A1BG PDGFRB PSG4 PSG7 PSG9 UNC5B CEACAM6 PTGFRN IGSF10 TYRO3 PSG8 NPHS1 NRCAM HMCN1 IGSF1 IL1RAP | 5.48e-06 | 421 | 187 | 16 | IPR003599 |
| Domain | Ig_2 | 8.41e-06 | 73 | 187 | 7 | PF13895 | |
| Domain | IG_LIKE | A1BG PDGFRB PSG4 PSG7 PSG9 UNC5B CEACAM6 PTGFRN IGSF10 TYRO3 PSG8 NPHS1 NRCAM HMCN1 IGSF1 IL1RAP | 3.64e-05 | 491 | 187 | 16 | PS50835 |
| Domain | - | A1BG PDGFRB PSG4 PSG7 PSG9 UNC5B CEACAM6 PTGFRN IGSF10 TYRO3 PSG8 NPHS1 NRCAM PKHD1L1 IFNGR1 HMCN1 IGSF1 IL1RAP IL5RA | 3.91e-05 | 663 | 187 | 19 | 2.60.40.10 |
| Domain | Ig-like_dom | A1BG PDGFRB PSG4 PSG7 PSG9 UNC5B CEACAM6 PTGFRN IGSF10 TYRO3 PSG8 NPHS1 NRCAM HMCN1 IGSF1 IL1RAP | 4.85e-05 | 503 | 187 | 16 | IPR007110 |
| Domain | Ig-like_fold | A1BG PDGFRB PSG4 PSG7 PSG9 UNC5B CEACAM6 PTGFRN IGSF10 TYRO3 PSG8 NPHS1 NRCAM PKHD1L1 IFNGR1 HMCN1 IGSF1 IL1RAP IL5RA | 9.01e-05 | 706 | 187 | 19 | IPR013783 |
| Domain | ASH | 9.97e-05 | 2 | 187 | 2 | IPR031549 | |
| Domain | ASH | 9.97e-05 | 2 | 187 | 2 | PF15780 | |
| Domain | Ig_V-set | 1.83e-04 | 199 | 187 | 9 | IPR013106 | |
| Domain | SNF2_N | 2.81e-04 | 32 | 187 | 4 | IPR000330 | |
| Domain | SNF2_N | 2.81e-04 | 32 | 187 | 4 | PF00176 | |
| Domain | DUF4208 | 2.97e-04 | 3 | 187 | 2 | PF13907 | |
| Domain | DUF4208 | 2.97e-04 | 3 | 187 | 2 | IPR025260 | |
| Domain | DUF4208 | 2.97e-04 | 3 | 187 | 2 | SM01176 | |
| Domain | Stereocilin-rel | 2.97e-04 | 3 | 187 | 2 | IPR026664 | |
| Domain | V_ATPase_I | 5.90e-04 | 4 | 187 | 2 | PF01496 | |
| Domain | V-type_ATPase_116kDa_su_euka | 5.90e-04 | 4 | 187 | 2 | IPR026028 | |
| Domain | V-ATPase_116kDa_su | 5.90e-04 | 4 | 187 | 2 | IPR002490 | |
| Domain | GDS_CDC24_CS | 6.09e-04 | 39 | 187 | 4 | IPR001331 | |
| Domain | Ig_I-set | 6.71e-04 | 190 | 187 | 8 | IPR013098 | |
| Domain | I-set | 6.71e-04 | 190 | 187 | 8 | PF07679 | |
| Domain | RhoGEF | 6.82e-04 | 70 | 187 | 5 | PF00621 | |
| Domain | DH_2 | 6.82e-04 | 70 | 187 | 5 | PS50010 | |
| Domain | - | 7.28e-04 | 71 | 187 | 5 | 1.20.900.10 | |
| Domain | DH-domain | 7.28e-04 | 71 | 187 | 5 | IPR000219 | |
| Domain | - | 7.28e-04 | 71 | 187 | 5 | 1.10.418.10 | |
| Domain | Helicase_C | 7.28e-04 | 107 | 187 | 6 | PF00271 | |
| Domain | HELICc | 7.28e-04 | 107 | 187 | 6 | SM00490 | |
| Domain | Helicase_C | 7.64e-04 | 108 | 187 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 8.02e-04 | 109 | 187 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 8.02e-04 | 109 | 187 | 6 | PS51192 | |
| Domain | DEXDc | 8.02e-04 | 109 | 187 | 6 | SM00487 | |
| Domain | CH | 8.26e-04 | 73 | 187 | 5 | PS50021 | |
| Domain | Helicase_ATP-bd | 8.41e-04 | 110 | 187 | 6 | IPR014001 | |
| Domain | - | 8.79e-04 | 74 | 187 | 5 | 3.40.50.410 | |
| Domain | CH-domain | 9.34e-04 | 75 | 187 | 5 | IPR001715 | |
| Domain | VWFA | 1.40e-03 | 82 | 187 | 5 | PS50234 | |
| Domain | - | 1.46e-03 | 6 | 187 | 2 | 3.90.1290.10 | |
| Domain | VWA | 1.55e-03 | 84 | 187 | 5 | SM00327 | |
| Domain | Chromo_domain | 1.71e-03 | 24 | 187 | 3 | IPR023780 | |
| Domain | CAMSAP_CH | 2.03e-03 | 7 | 187 | 2 | PF11971 | |
| Domain | APC_su10/DOC_dom | 2.03e-03 | 7 | 187 | 2 | IPR004939 | |
| Domain | Plectin | 2.03e-03 | 7 | 187 | 2 | PF00681 | |
| Domain | DOC | 2.03e-03 | 7 | 187 | 2 | PS51284 | |
| Domain | ANAPC10 | 2.03e-03 | 7 | 187 | 2 | PF03256 | |
| Domain | Plectin_repeat | 2.03e-03 | 7 | 187 | 2 | IPR001101 | |
| Domain | CAMSAP_CH | 2.03e-03 | 7 | 187 | 2 | IPR022613 | |
| Domain | APC10 | 2.03e-03 | 7 | 187 | 2 | SM01337 | |
| Domain | PLEC | 2.03e-03 | 7 | 187 | 2 | SM00250 | |
| Pubmed | A1BG PSG4 PSG9 CEACAM6 PTGFRN IGSF10 TYRO3 PSG8 NRCAM HMCN1 IGSF1 IL1RAP | 1.48e-10 | 162 | 195 | 12 | 25826454 | |
| Pubmed | SCFD2 SELENOT ATP6V0A1 UNC5B PAK4 UTP14A CHD1 PSMD8 NDUFS1 PLEKHG1 SENP1 GANAB COCH ASPM SDHA TNPO1 HECTD3 ESYT1 GPAT3 CEP192 PDHX GSR WDR19 UBE2O EFNB2 SLC20A1 MACF1 CRYBG3 SEC63 OGA VPS13B | 2.92e-10 | 1487 | 195 | 31 | 33957083 | |
| Pubmed | EPPK1 UTP14A CUL9 CHD1 CHD2 URB2 NDUFS1 GANAB MED12 SDHA TNPO1 XRN2 NUP98 FRYL CHD7 MSH6 UBE2O MACF1 SPEN | 6.08e-09 | 653 | 195 | 19 | 22586326 | |
| Pubmed | CUL9 URB2 SLC12A5 PLEKHG1 GANAB CAMSAP2 NRCAM ALS2 CEP192 KANSL1 MACF1 ASB1 SPEN VPS13B | 8.70e-08 | 407 | 195 | 14 | 12693553 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 6.59e-07 | 13 | 195 | 4 | 1985902 | |
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 6.59e-07 | 13 | 195 | 4 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 6.59e-07 | 13 | 195 | 4 | 16638824 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 20044046 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 32150576 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 6265583 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 6.59e-07 | 13 | 195 | 4 | 12832451 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 25406283 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 6.59e-07 | 13 | 195 | 4 | 21670291 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 22162753 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 2702644 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 8380065 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 1279194 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 25724769 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 26374765 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 6.59e-07 | 13 | 195 | 4 | 22092845 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 11801635 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 28913658 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 6.59e-07 | 13 | 195 | 4 | 8500759 | |
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 6.59e-07 | 13 | 195 | 4 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 6.59e-07 | 13 | 195 | 4 | 23800882 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 19285068 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 21760897 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 1719235 | ||
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 6.59e-07 | 13 | 195 | 4 | 1326665 | |
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 6.59e-07 | 13 | 195 | 4 | 39168268 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 8402684 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 16619040 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 6.59e-07 | 13 | 195 | 4 | 8209741 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 6.59e-07 | 13 | 195 | 4 | 21949477 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 26219866 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 2133556 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 32521208 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 19406938 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 19621080 | ||
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 6.59e-07 | 13 | 195 | 4 | 29967450 | |
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 6.59e-07 | 13 | 195 | 4 | 19358828 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 16680193 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 1653760 | ||
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 6.59e-07 | 13 | 195 | 4 | 34058224 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 10964771 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 32169849 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 22469976 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 6.59e-07 | 13 | 195 | 4 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 6.59e-07 | 13 | 195 | 4 | 28035001 | |
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 6.59e-07 | 13 | 195 | 4 | 15316023 | |
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 6.59e-07 | 13 | 195 | 4 | 23935487 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 15331748 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 6.59e-07 | 13 | 195 | 4 | 22406619 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 7628460 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 6.59e-07 | 13 | 195 | 4 | 25972571 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 19008452 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 18544705 | ||
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 6.59e-07 | 13 | 195 | 4 | 15220458 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 18843289 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 15207636 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 21081647 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 11133662 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 11483763 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 2164599 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 29396368 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 18003729 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 26284027 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 6.59e-07 | 13 | 195 | 4 | 33352461 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 38381498 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 20739537 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 1633107 | ||
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 6.59e-07 | 13 | 195 | 4 | 27695943 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 20404914 | ||
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 26911181 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 6.59e-07 | 13 | 195 | 4 | 32027621 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 6.59e-07 | 13 | 195 | 4 | 27777319 | |
| Pubmed | 6.59e-07 | 13 | 195 | 4 | 18848945 | ||
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 37531413 | ||
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 9.18e-07 | 14 | 195 | 4 | 34666041 | |
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 34619794 | ||
| Pubmed | SHP1 phosphatase-dependent T cell inhibition by CEACAM1 adhesion molecule isoforms. | 9.18e-07 | 14 | 195 | 4 | 17081782 | |
| Pubmed | Loss of Ceacam1 promotes prostate cancer progression in Pten haploinsufficient male mice. | 9.18e-07 | 14 | 195 | 4 | 32209360 | |
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 11994468 | ||
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 11850617 | ||
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 20381490 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 9.18e-07 | 14 | 195 | 4 | 26196244 | |
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 8896983 | ||
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 22962327 | ||
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 17623671 | ||
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 26846848 | ||
| Pubmed | CEACAM1, a SOX9 direct transcriptional target identified in the colon epithelium. | 9.18e-07 | 14 | 195 | 4 | 18794798 | |
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 23469261 | ||
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 18454175 | ||
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 22159884 | ||
| Pubmed | 9.18e-07 | 14 | 195 | 4 | 29907459 | ||
| Cytoband | 19q13.2 | 7.34e-06 | 164 | 196 | 7 | 19q13.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 8.10e-07 | 11 | 130 | 4 | 1315 | |
| GeneFamily | Immunoglobulin like domain containing | 1.08e-05 | 193 | 130 | 9 | 594 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.12e-04 | 66 | 130 | 5 | 722 | |
| GeneFamily | V-type ATPases | 5.79e-04 | 23 | 130 | 3 | 415 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.09e-03 | 161 | 130 | 6 | 593 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 1.16e-03 | 163 | 130 | 6 | 590 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.40e-03 | 8 | 130 | 2 | 939 | |
| GeneFamily | CD molecules|I-set domain containing|Immunoglobulin like domain containing|Interleukin receptors|TIR domain containing | 3.40e-03 | 42 | 130 | 3 | 602 | |
| GeneFamily | Endogenous ligands|Interleukins | 3.63e-03 | 43 | 130 | 3 | 601 | |
| Coexpression | CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_1 | ABAT EPPK1 FAM178B UTP14A NAP1L2 NALF1 SVIL ASPM NRCAM ESYT1 MREG TKFC HMCN1 IGSF1 RIMS2 MYBL1 | 2.40e-06 | 534 | 193 | 16 | M12522 |
| Coexpression | GSE12366_GC_VS_NAIVE_BCELL_DN | 1.52e-05 | 195 | 193 | 9 | M3170 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | CHD1 NALF1 BRCA2 KIF2A DMD CAMSAP2 TUT4 NUP98 FRYL MSH6 LTN1 HLTF MACF1 CRYBG3 IL1RAP SPEN VPS13B MYBL1 SOS2 | 2.02e-05 | 856 | 193 | 19 | M4500 |
| Coexpression | DOUGLAS_BMI1_TARGETS_DN | SLFN5 PCMTD1 SLC10A7 IVD ARL6IP1 PGAP2 OAS3 SKP2 TKFC EXD2 IL1RAP | 2.30e-05 | 314 | 193 | 11 | M14279 |
| Coexpression | GSE4984_GALECTIN1_VS_LPS_STIM_DC_UP | 2.45e-05 | 159 | 193 | 8 | M6502 | |
| Coexpression | EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN | 3.01e-05 | 49 | 193 | 5 | M7778 | |
| Coexpression | KIM_WT1_TARGETS_12HR_UP | 3.34e-05 | 166 | 193 | 8 | M15535 | |
| Coexpression | LAKE_ADULT_KIDNEY_C29_UNKNOWN_NOVEL_PT_CFH_POS_SUBPOPULATION_S2 | 4.25e-05 | 86 | 193 | 6 | M39248 | |
| Coexpression | HARALAMBIEVA_PBMC_FLUARIX_AGE_50_74YO_CORR_WITH_28D_MEM_B_CELL_RESPONSE_AT_28DY_LATE_GENE_EXPR_INDIVID_GENE_MODELS_PRED_PEAK_B_CELL_ELISPOT_RESP_NEGATIVE | 4.54e-05 | 10 | 193 | 3 | M41091 | |
| Coexpression | GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP | 5.93e-05 | 180 | 193 | 8 | M8239 | |
| ToppCell | COVID-19-Epithelial-Ionocytes|Epithelial / Condition, Lineage and Cell class | URB2 COCH ATP6V1C2 VIPR2 FAM3B ATP6V0A4 NEURL1 CACNA2D3 CXCR2 | 1.11e-07 | 181 | 195 | 9 | 4a8d4f2709c1b25f908867f1b2fae1d2d0abf1d4 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 184 | 195 | 9 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 184 | 195 | 9 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.28e-07 | 184 | 195 | 9 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.91e-07 | 193 | 195 | 9 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-Transitional_AT2|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | RHBDL2 COCH ATP6V1C2 MTUS2 FAM3B GPRC6A ATL1 ATP6V0A4 NEURL1 | 2.48e-07 | 199 | 195 | 9 | cd581d7330b471431ef427f8a4f5be553f70e068 |
| ToppCell | droplet-Limb_Muscle-nan-18m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-07 | 150 | 195 | 8 | a003cbaf25a1b5ad4d361dcf162afe0c4b8b78f8 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Granulocytic-Mast_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.74e-07 | 161 | 195 | 8 | c54010d88f1ecb6e0235bb66084876a4d5bf1ecd | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-07 | 172 | 195 | 8 | 7c085c02b59e24e2a2cd393b5e692f9fb19257fe | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-07 | 172 | 195 | 8 | c5caae0b21e35a2d5dcd898fbfa1ef33f92c019f | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.03e-06 | 174 | 195 | 8 | 3c47d069bd836599a8d40eae485c23d4d3487517 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-06 | 177 | 195 | 8 | d3e6c768b88b7906f3c7fdd00ba20842212c14b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-06 | 177 | 195 | 8 | f8f101c772c043636bedd6b2ec81409b1d2599bf | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-NK_activated|COVID-19_Mild / Disease group, lineage and cell class | 1.17e-06 | 177 | 195 | 8 | 6978a22fef40c8b455342373abe7593f5ede0fa4 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-06 | 177 | 195 | 8 | 936ab2b180a052387124f68d0c7f41c0b164e748 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-NK_cell-NK_activated-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.17e-06 | 177 | 195 | 8 | d5aeda113afaa2425874394610344570c9078478 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_3|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.64e-06 | 185 | 195 | 8 | daea170d827226dda6750bf1838ffd82f070c4d4 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 192 | 195 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 193 | 195 | 8 | 027e098ad018e782287f84eee0f77551018f2196 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-06 | 193 | 195 | 8 | c5463a87f20b3a7f7ffda677b2f5a0e9e49d6685 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.71e-06 | 198 | 195 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.92e-06 | 200 | 195 | 8 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 160 | 195 | 7 | 56e6f4b82b5dc41c45f9d253c2db314a6f702b84 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.87e-06 | 160 | 195 | 7 | bb1b966fb9e801db15e67d03e49db4609d6f935a | |
| ToppCell | facs-Marrow-Granulocytes-18m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.16e-06 | 161 | 195 | 7 | 60f433eab9d5531bdf6aa86b0265f20b866b904c | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.74e-06 | 166 | 195 | 7 | ec7bd549bda5f18aca8aebce5ba479a81abbbeda | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 9.83e-06 | 169 | 195 | 7 | e68e6c24606fd46eca6f86bb63fa86ea17879ae2 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-05 | 177 | 195 | 7 | 6d89042bda8e244babb68929e84b25edcb545a77 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-05 | 177 | 195 | 7 | 338bdda26796bf4e16072878c070212d1006cf57 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-05 | 177 | 195 | 7 | daaccf1249dcf816df4caca695a944f53078291a | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Neuro-endocrine/ionocytic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.33e-05 | 177 | 195 | 7 | c5a16f984c836dbf7d0faf061677844167ab612a | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Myeloid-cDC2|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.38e-05 | 178 | 195 | 7 | 32120936a524c38e621bd2fca17524fef74422e0 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.53e-05 | 181 | 195 | 7 | 9ede19228ba5c0668a9c06c915510b95585216ef | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 1.83e-05 | 186 | 195 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.83e-05 | 186 | 195 | 7 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.83e-05 | 186 | 195 | 7 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T2|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.89e-05 | 187 | 195 | 7 | f3e37c18ac6471c7992609bbddfa4975571c815c | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.89e-05 | 187 | 195 | 7 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.89e-05 | 187 | 195 | 7 | f124d2c699b717b7c02a1a70493f515b83dc2f4c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 189 | 195 | 7 | 975c0f079903ae36b0ffa54e86294d42ec7697de | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.03e-05 | 189 | 195 | 7 | 7eb8f5a951e80f1cfac4d7c9eb169f4eb100c917 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-05 | 190 | 195 | 7 | edc0a0eb17abbecb0f06d302be3d4f8c1dd4f333 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.10e-05 | 190 | 195 | 7 | 3f0c7d130f66faea778fe567604edf1b4cdf85b3 | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-05 | 191 | 195 | 7 | 51cff0594ac7ad8c065c8ea2301f8c149bd062b4 | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-05 | 191 | 195 | 7 | a55b6f0a7ec1a8852ffca593cfdccd7edea09b7b | |
| ToppCell | droplet-Lung-30m-Endothelial-lymphatic_endothelial|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-05 | 191 | 195 | 7 | 38681a1b182d6af5cce85db5431b6eba4b20ad96 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.24e-05 | 192 | 195 | 7 | c09dcc73ff9c3855a0f3d7bfa0d5c99c09a117f2 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-05 | 195 | 195 | 7 | 3a0cad69cfc150a27a0666f612f5294c817197d7 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.48e-05 | 195 | 195 | 7 | 2b8ee7990267bb52b7e6ae03f509ffebf8908122 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-cDC2-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.48e-05 | 195 | 195 | 7 | cb27f6ca8b02438c353c9dff2f76d2656bb5b29a | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.48e-05 | 195 | 195 | 7 | 2e1df01bf6e4e98e6cd9fb50926e34c5077b8666 | |
| ToppCell | COVID-19_Moderate-cDC|World / disease group, cell group and cell class | 2.56e-05 | 196 | 195 | 7 | 92a236adf386f05d020b1954bbdc5bd32346cbf0 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 2.56e-05 | 196 | 195 | 7 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | LV-09._Endothelium_I|LV / Chamber and Cluster_Paper | 2.64e-05 | 197 | 195 | 7 | f9731d4d636e51b94a96805eee6afe9aedc175e3 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 2.64e-05 | 197 | 195 | 7 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 2.73e-05 | 198 | 195 | 7 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.73e-05 | 198 | 195 | 7 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_neuro-secretory-Ionocyte_n_Brush|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.73e-05 | 198 | 195 | 7 | dd0465b45b02cb8edf0914d19afb52fcaaeb012c | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.73e-05 | 198 | 195 | 7 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.73e-05 | 198 | 195 | 7 | 35499a5231818e3432cf69b5c4a58c02f7771db8 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-05 | 198 | 195 | 7 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | LA-10._Endothelium_II|LA / Chamber and Cluster_Paper | 2.78e-05 | 134 | 195 | 6 | 048fa6ccf305d22d9a53db4ab385f39f558010d8 | |
| ToppCell | control-HLA-DR+_CD83+_Monocyte|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.82e-05 | 199 | 195 | 7 | f1b370d2869ad29c9d8ff41fdcc486fffa781ee2 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(50)_cDC2|Transverse / shred on region, Cell_type, and subtype | 2.91e-05 | 200 | 195 | 7 | eea523f7512b54d7443651bce3ff6d043a9897aa | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.91e-05 | 200 | 195 | 7 | aa1a35dcca3b799241eef4237f6eb94660e019f0 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.91e-05 | 200 | 195 | 7 | a510deaada669e690329183e18df02870bd204b3 | |
| ToppCell | COVID-19_Severe-NK_activated|COVID-19_Severe / Disease condition and Cell class | 2.91e-05 | 200 | 195 | 7 | f1f6c7f7f75f891c9ccf6bf58f4d65b9cf10bbd8 | |
| ToppCell | Transverse-Dendritic_cell-cDC2|Transverse / Region, Cell class and subclass | 2.91e-05 | 200 | 195 | 7 | 80730a6372627543b84d8fb1b94c481db17c6500 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-NK_activated|COVID-19_Mild / Disease, condition lineage and cell class | 2.91e-05 | 200 | 195 | 7 | 2281debd86e5d92e8fe0397aec9ef670800f7471 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-05 | 200 | 195 | 7 | dd4228cbed8a4395166a6332e08d44d88bebe3b9 | |
| ToppCell | LPS-IL1RA-Hematopoietic_Mast-Mast_cells-Mast-cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.42e-05 | 139 | 195 | 6 | f1d1a51a79afdddc82e73cd29b3240e3e973db28 | |
| ToppCell | COVID-19-Fibroblasts-Mesothelial_FB|COVID-19 / group, cell type (main and fine annotations) | 3.70e-05 | 141 | 195 | 6 | 7e6dcccb74e7ee90b69dc91b59491b84f3a713c9 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil-Neutrophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.33e-05 | 145 | 195 | 6 | ab0e254a8d01021619853a6c175f620ccef217d8 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Neutrophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.33e-05 | 145 | 195 | 6 | 2beb4ea3838796c580076ab7769de877a3a0552c | |
| ToppCell | facs-Skin-nan-18m-Myeloid-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 149 | 195 | 6 | 23a1b95c12f2e3708dc003e13fab423e89821f11 | |
| ToppCell | facs-Skin-nan-18m-Myeloid|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 149 | 195 | 6 | bb18a18b891af85849b9658d774053f839c9a8e1 | |
| ToppCell | facs-Skin-nan-18m-Myeloid-macrophage|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.04e-05 | 149 | 195 | 6 | c53a3226adc8fd0eaaa842b6a96442287580cbe0 | |
| ToppCell | LPS_only-Hematopoietic_Mast-Mast_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.23e-05 | 150 | 195 | 6 | 7290e9a812b1b2f919e67ccde0acf52687ab138f | |
| ToppCell | LPS_only-Hematopoietic_Mast|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.23e-05 | 150 | 195 | 6 | 2c5078a1f769ba8153dee756b53d28eb7b434a96 | |
| ToppCell | VE-CD8-memory_CD4|VE / Condition, Cell_class and T cell subcluster | 5.63e-05 | 152 | 195 | 6 | 9401b7770c1bdc87eba25e82922f5dd1c4fa37ee | |
| ToppCell | facs-Trachea-24m-Hematologic-myeloid-granulocyte-granulocyte_l8|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.84e-05 | 153 | 195 | 6 | 338684d420b01e32918fa19048ccdda234942ce1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.50e-05 | 156 | 195 | 6 | b3f10cd044f24807576e7d56e51df7064dbf6c50 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 6.50e-05 | 156 | 195 | 6 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-cardiac_mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 158 | 195 | 6 | 9596b7b0f6f5157a43d67d2e67fb75a2624a6bb9 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 158 | 195 | 6 | 7ebc8b778c97c0faa79e2d80c98b887fa635f901 | |
| ToppCell | droplet-Heart-nan-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.98e-05 | 158 | 195 | 6 | 81a5a73090804d41429d297ba2462a842f39d380 | |
| ToppCell | Frontal_cortex-Hematopoietic-MICROGLIA|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 7.22e-05 | 159 | 195 | 6 | 41d2c1e71f6983156f8cc8ec5f69e025e5700f46 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-05 | 160 | 195 | 6 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.48e-05 | 160 | 195 | 6 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 162 | 195 | 6 | e81dec1db8e5a808d96e58410c91961e5d065c94 | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 162 | 195 | 6 | d19b469f64c9064cfb82dadb6c8135e28949a02a | |
| ToppCell | facs-Lung-Endomucin_-18m-Lymphocytic-B_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.01e-05 | 162 | 195 | 6 | 10c2aa047f33f48e4abe676236bbdb593079dd1d | |
| ToppCell | 343B-Myeloid-Dendritic-cDC_activated|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 8.57e-05 | 164 | 195 | 6 | eae6d440877b292ad18dc4bd02802dda5b2f9c60 | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-05 | 165 | 195 | 6 | f8bfe336b9a4460b9349c01acd0bd3167812662f | |
| ToppCell | facs-Heart-LA-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-05 | 165 | 195 | 6 | 95866f7cc6eb1bb51a034a104a0eb2a53b0256f2 | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.01e-05 | 103 | 195 | 5 | eb9f008b5fb8a01df8ea4faf6e6aebc1a9db9bd3 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.16e-05 | 166 | 195 | 6 | bcdaab49bde5beba750b76fdcc3781a3c12c4fff | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.16e-05 | 166 | 195 | 6 | 5e3b998d740b24f790fad37350d704ca0ea10b77 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Neuro-endocrine/ionocytic-ionocyte-Ionocyte-Ionocyte_L.0.7.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 9.47e-05 | 167 | 195 | 6 | 7ec032a98a13504d15c7e3a4e259278d07f40180 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-3m-Epithelial-nan|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 167 | 195 | 6 | 69caf4a53805f8c104d7dd8f88665fc992e23720 | |
| Drug | AC1L1IPV | 1.56e-06 | 43 | 192 | 6 | CID000004683 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 5.85e-07 | 152 | 187 | 9 | DOID:0060041 (implicated_via_orthology) | |
| Disease | cD177 antigen measurement | 4.46e-06 | 18 | 187 | 4 | EFO_0021866 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.90e-04 | 45 | 187 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | pregnancy-specific beta-1-glycoprotein 9 measurement | 2.38e-04 | 4 | 187 | 2 | EFO_0801909 | |
| Disease | autosomal recessive osteopetrosis 1 (implicated_via_orthology) | 3.95e-04 | 5 | 187 | 2 | DOID:0110942 (implicated_via_orthology) | |
| Disease | polycystic liver disease (is_implicated_in) | 3.95e-04 | 5 | 187 | 2 | DOID:0050770 (is_implicated_in) | |
| Disease | Schizophrenia | A1BG PDGFRB IL17C NDUFS1 SLC12A5 NRXN1 TMEM245 KIF2A MED12 SDHA VIPR2 PTPN5 EFNB2 SLC18A2 RIMS2 | 5.36e-04 | 883 | 187 | 15 | C0036341 |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 5.89e-04 | 6 | 187 | 2 | EFO_0801907 | |
| Disease | Flaccid Muscle Tone | 5.89e-04 | 6 | 187 | 2 | C0026825 | |
| Disease | Neonatal Hypotonia | 5.89e-04 | 6 | 187 | 2 | C2267233 | |
| Disease | Muscle Tone Atonic | 5.89e-04 | 6 | 187 | 2 | C0427202 | |
| Disease | Floppy Muscles | 5.89e-04 | 6 | 187 | 2 | C0427201 | |
| Disease | Adult only | 5.89e-04 | 6 | 187 | 2 | C3842001 | |
| Disease | Unilateral Hypotonia | 5.89e-04 | 6 | 187 | 2 | C0751330 | |
| Disease | R-6-hydroxywarfarin measurement | 8.14e-04 | 114 | 187 | 5 | EFO_0803327 | |
| Disease | CHARGE syndrome (implicated_via_orthology) | 8.22e-04 | 7 | 187 | 2 | DOID:0050834 (implicated_via_orthology) | |
| Disease | Cerebral ventriculomegaly | 8.22e-04 | 7 | 187 | 2 | C1531647 | |
| Disease | Hydrocephalus Ex-Vacuo | 8.22e-04 | 7 | 187 | 2 | C0270720 | |
| Disease | Communicating Hydrocephalus | 8.22e-04 | 7 | 187 | 2 | C0009451 | |
| Disease | Fetal Cerebral Ventriculomegaly | 8.22e-04 | 7 | 187 | 2 | C2936718 | |
| Disease | Post-Traumatic Hydrocephalus | 8.22e-04 | 7 | 187 | 2 | C0477432 | |
| Disease | Obstructive Hydrocephalus | 8.22e-04 | 7 | 187 | 2 | C0549423 | |
| Disease | Parkinsonism, Juvenile | 8.97e-04 | 30 | 187 | 3 | C0752105 | |
| Disease | Congenital Hydrocephalus | 1.09e-03 | 8 | 187 | 2 | C0020256 | |
| Disease | Aqueductal Stenosis | 1.09e-03 | 8 | 187 | 2 | C2936786 | |
| Disease | renal tubular acidosis (implicated_via_orthology) | 1.09e-03 | 8 | 187 | 2 | DOID:14219 (implicated_via_orthology) | |
| Disease | prostate cancer (implicated_via_orthology) | 1.19e-03 | 33 | 187 | 3 | DOID:10283 (implicated_via_orthology) | |
| Disease | Liver Cirrhosis, Experimental | ABAT PDGFRB ARL11 IVD SERPINA4 FGR GOT1 MAP3K8 NOX4 IFNGR1 TKFC SLC17A1 SLC20A1 | 1.39e-03 | 774 | 187 | 13 | C0023893 |
| Disease | Hydrocephalus | 1.40e-03 | 9 | 187 | 2 | C0020255 | |
| Disease | endometrial cancer (is_implicated_in) | 1.53e-03 | 36 | 187 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | ovarian neoplasm | 1.67e-03 | 134 | 187 | 5 | C0919267 | |
| Disease | cataract (implicated_via_orthology) | 1.79e-03 | 38 | 187 | 3 | DOID:83 (implicated_via_orthology) | |
| Disease | unipolar depression | PIPOX PCMTD1 METTL21EP SLC12A5 NALF1 NRXN1 SVIL KIF2A DMD MED12 TRAPPC9 OTOA CNTNAP1 CHD7 INTS9 LY75 CACNA2D3 | 1.80e-03 | 1206 | 187 | 17 | EFO_0003761 |
| Disease | Malignant neoplasm of ovary | 1.84e-03 | 137 | 187 | 5 | C1140680 | |
| Disease | 3-hydroxy-1-methylpropylmercapturic acid measurement | 1.91e-03 | 352 | 187 | 8 | EFO_0007015 | |
| Disease | cognitive function measurement, self reported educational attainment | 2.01e-03 | 355 | 187 | 8 | EFO_0004784, EFO_0008354 | |
| Disease | cortical thickness | CPA4 CPAMD8 WWOX FAM178B CUL9 PLEKHM1 PLEKHG1 COCH NALF1 CHD7 EFNB2 KANSL1 LRP4 MACF1 CACNA2D3 SOS2 | 2.02e-03 | 1113 | 187 | 16 | EFO_0004840 |
| Disease | ovarian carcinoma, COVID-19 | 2.12e-03 | 11 | 187 | 2 | EFO_0001075, MONDO_0100096 | |
| Disease | beta thalassemia (is_marker_for) | 2.12e-03 | 11 | 187 | 2 | DOID:12241 (is_marker_for) | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 2.12e-03 | 11 | 187 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | Hereditary hearing loss and deafness | 2.43e-03 | 146 | 187 | 5 | cv:C0236038 | |
| Disease | periodontitis (is_marker_for) | 2.53e-03 | 12 | 187 | 2 | DOID:824 (is_marker_for) | |
| Disease | childhood trauma measurement, smoking behaviour measurement | 2.92e-03 | 45 | 187 | 3 | EFO_0005671, EFO_0007979 | |
| Disease | Adenoid Cystic Carcinoma | 3.82e-03 | 100 | 187 | 4 | C0010606 | |
| Disease | inherited metabolic disorder (is_implicated_in) | 3.97e-03 | 15 | 187 | 2 | DOID:655 (is_implicated_in) | |
| Disease | Squamous cell carcinoma of the head and neck | 4.41e-03 | 52 | 187 | 3 | C1168401 | |
| Disease | Muscle hypotonia | 5.10e-03 | 17 | 187 | 2 | C0026827 | |
| Disease | cortical surface area measurement | CPA4 SCFD2 CPAMD8 WWOX FAM178B CUL9 PLEKHM1 PLEKHG1 COCH NALF1 FRYL CHD7 CCDC88C EFNB2 KANSL1 MACF1 SOS2 | 5.43e-03 | 1345 | 187 | 17 | EFO_0010736 |
| Disease | sphingosine 1-phosphate measurement | 5.72e-03 | 18 | 187 | 2 | EFO_0800185 | |
| Disease | Malignant neoplasm of endometrium | 5.72e-03 | 18 | 187 | 2 | C0007103 | |
| Disease | Carcinoma in situ of endometrium | 5.72e-03 | 18 | 187 | 2 | C0346191 | |
| Disease | pneumonia, COVID-19 | 5.88e-03 | 113 | 187 | 4 | EFO_0003106, MONDO_0100096 | |
| Disease | urate measurement, spine bone mineral density | 5.98e-03 | 58 | 187 | 3 | EFO_0004531, EFO_0007701 | |
| Disease | Prostatic Neoplasms | 6.15e-03 | 616 | 187 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 6.15e-03 | 616 | 187 | 10 | C0376358 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SGLVSQQLPWLFEKD | 831 | Q14146 | |
| GKVLQASVLDDWFPL | 421 | Q9BSJ8 | |
| SSQFTAWKAALPLIL | 246 | A8MVZ5 | |
| TNLLWSPDGSKILAT | 291 | Q9NRG9 | |
| QPQWRTDKGLLTFVD | 736 | P78357 | |
| VADGLANLNPVTWIK | 506 | O42043 | |
| SNLQVGLWPEKTSFL | 2206 | Q68DQ2 | |
| QRKFWPATLSILGES | 1526 | Q96Q42 | |
| ANLNLVKWESLGPES | 261 | Q9Y576 | |
| WAIGRVPNTKDLSLN | 331 | P00390 | |
| PSNLLFTSASGELWK | 251 | A6NHX0 | |
| SLFPGLRDILNTWEK | 226 | Q96LT6 | |
| ILAPRIFGSNKWTTE | 86 | Q15041 | |
| IKGSWQPVGDLLIDS | 2956 | P11532 | |
| GDENIKSFIWDLITP | 1656 | Q9P2D1 | |
| KSFIWDLITPTADGQ | 1661 | Q9P2D1 | |
| ITGTPLQNSLKELWS | 641 | O14646 | |
| RSIPKDTWNLLLDFS | 206 | Q96GG9 | |
| WLNFILTPDDFTVKT | 706 | Q8IZT6 | |
| SINSDWKIELPGEFQ | 721 | Q8TE56 | |
| LQAFGVSAPKLAWLS | 256 | A0A1B0GUU1 | |
| NEELLWKLQTGDPTS | 1326 | Q5JR59 | |
| PDFWLTVLKNVDTLT | 241 | Q9ULW6 | |
| ESNWPIRFSAIDKLG | 491 | Q4ADV7 | |
| LWGKSSLNTVIFTEP | 411 | Q9NV88 | |
| LLKQLEPTAWLDSGT | 126 | P54829 | |
| LSQFPDSLLWKEASA | 31 | Q17RG1 | |
| KIDPTADTSFLGWVI | 66 | Q8NHS3 | |
| NTTFGEIIIGLWKSP | 376 | Q8NHS3 | |
| IGNLPVNLISEWKEF | 1296 | O94822 | |
| LWAESESLLKPLANV | 31 | P04217 | |
| GLPEALQSLWSLLKS | 161 | Q969Q4 | |
| SQCVPFLISLGKSWL | 651 | Q7RTW8 | |
| IVFTWTKNGVPLDLQ | 871 | O60500 | |
| SITPINEWLLKGLQT | 96 | Q0GE19 | |
| WDFGNKELLITSQPE | 236 | Q9UHJ9 | |
| PKTITGSETNLLFFW | 211 | P01583 | |
| QLLETPESWAKETFL | 1591 | P52948 | |
| TFLKNNLPTAISDWL | 241 | P31513 | |
| GWAKAQEATRLTQLP | 91 | Q3ZCV2 | |
| PQTLGLAKDAWEISR | 246 | P09769 | |
| DNLVITWKPLNGFES | 761 | Q92823 | |
| FSELIEQKWPGSQDL | 256 | Q86W28 | |
| KDVLWFRPTLLNDTG | 96 | Q9NPH3 | |
| WVLSQVTLKESGPAL | 16 | A0A0C4DH43 | |
| KEVLLTASLLTFWNP | 16 | P40199 | |
| AVGAWLVPIDQLKSS | 2036 | Q2LD37 | |
| TWLGDPSKNLLLAEV | 381 | P80404 | |
| LAPLFGSLKWNNITE | 226 | Q8IY21 | |
| LFLQSPLVTWVKTFG | 11 | Q9P219 | |
| WVNLEGKASPLSLLQ | 111 | Q9NVH0 | |
| KSLLLSGQEVPWLSS | 61 | P41279 | |
| TIKFQEFSPNLWGLE | 111 | P52799 | |
| WESKNILAVSFAPLV | 206 | Q96MG8 | |
| FHSTQWLRGDPIKIL | 46 | O00330 | |
| LFALTLPIWAASKVN | 96 | P25025 | |
| QGQDPWIISLSSFLK | 796 | O94915 | |
| WIISLSSFLKQENLP | 801 | O94915 | |
| AVPAEFAWTIKLTGV | 451 | P04066 | |
| TRFEAWNIIKALPDG | 1296 | Q14005 | |
| LENGSEWKPTSFFLL | 601 | Q5W0B1 | |
| LTPSWREVDLQSLKG | 886 | Q7Z3B3 | |
| ALILNLQKSPFTGTW | 1061 | O60449 | |
| WFTDLAGTKPLTQLA | 116 | Q93074 | |
| AKWGQALPVALVSSL | 56 | Q9P0M4 | |
| KWGAQFLTELAPLSI | 516 | Q05C16 | |
| VKELSWGVALDTNFP | 171 | A6NDL7 | |
| NKAGLVFPTEVWTAL | 621 | Q9ULB1 | |
| LLSLQTEDGFWKLTP | 1576 | Q9UKK3 | |
| WDSATKQLLGLQPIS | 1696 | Q9UKK3 | |
| KFWITNGPDADVLIV | 196 | P26440 | |
| LIPGSQFWDASKTLR | 621 | P52701 | |
| SSWVFIAAKGLELPS | 186 | P58499 | |
| ITDGNPKLTLGLIWT | 161 | Q9UPN3 | |
| TPFASILNTLLDDWK | 436 | Q9NPH5 | |
| FKDGWPVSLSNSVRI | 2421 | Q96RW7 | |
| FQPWELLGVLKNVTF | 441 | Q5T6X5 | |
| VPQFLSGQLSIKLWF | 801 | Q9UQ26 | |
| RWKDTVLDGFPNQLT | 676 | Q3MJ16 | |
| WGVGSSPQRDDLKLL | 581 | O00139 | |
| LAGKTPTDLVQLWQA | 311 | Q9GZV1 | |
| WVLSDGTEVKPLQFT | 1876 | Q6WRI0 | |
| AETNFPLAPWKNLTL | 596 | Q8N6C5 | |
| IQTPDFEGLSWKQAL | 2571 | Q4G0P3 | |
| GTRLSIQWEKPVSAF | 251 | Q01344 | |
| TGIQIWSEIFLINKP | 121 | Q8WXF7 | |
| EDNTSAPSLFKLGWL | 961 | Q8WTW3 | |
| QWRPESKSGLLTLFA | 3126 | P51587 | |
| INPVTREWKDGLFST | 2171 | Q9UFH2 | |
| TLVGQLPDSSLKNWL | 176 | Q53EU6 | |
| QIPLSVVKLWASAFG | 36 | Q8IZS8 | |
| GTPLQNSLKELWSLL | 646 | O14647 | |
| PKFSLSDWDIVLATI | 156 | A8MYV0 | |
| VFWINPKTGELQLVT | 511 | Q6ZTQ4 | |
| KPALSAATWQGLVVD | 241 | Q8N1L9 | |
| NQIIPTAEETWLGLK | 396 | Q9UI42 | |
| LDSVLQKTVPWGVAF | 401 | O75417 | |
| GDVAAALPVVKWLSQ | 1391 | Q8IZJ3 | |
| FQSWSGPEKLLALDE | 241 | Q969H0 | |
| VWPSLQDRFSSLKGV | 76 | Q99871 | |
| LSNPELFEEWTGNVK | 311 | P17174 | |
| ILGADPQFGLIKAWS | 36 | Q9BRF8 | |
| AGLKELQAVSPSRIW | 411 | Q9NWL6 | |
| DIPSILSNKQFLAWG | 1761 | Q8TEP8 | |
| AAELLATWTDKSPLF | 206 | Q7Z6J4 | |
| PIFQNLWKNLDETLG | 516 | Q8IWT3 | |
| GTPIQNSLKDLWSLL | 586 | Q14527 | |
| IFSVGVAWAPLDDLK | 496 | O43405 | |
| KGVLLTASLLNFWNP | 16 | Q00888 | |
| WQLVASFLKLPISGT | 116 | Q8WUM9 | |
| LTFKVTADLPIVWGN | 2441 | Q6ZTR5 | |
| LAWLVAKAFGTENVP | 36 | Q08AD1 | |
| WAEIAKLLPGRTDNS | 161 | P10243 | |
| FVPLQIWSKVLAISG | 51 | P11049 | |
| ITIFNSSIKGSLWIP | 236 | P15260 | |
| EWLSEFKALPDTQIT | 11 | Q8IXS8 | |
| TDIPDFLWGLSEVQK | 61 | A6NM36 | |
| PTVLWFKDNRTLGDS | 346 | P09619 | |
| KFTGLPRQWQSLIEE | 31 | O96013 | |
| GKANGEPTWALLLTA | 551 | Q9H2X9 | |
| ALKSWTDVSLLPAFD | 536 | Q9Y6K5 | |
| QLLKATEPGLFGVWA | 606 | Q9UN66 | |
| LTNVKAPLHLDVTWG | 76 | Q96S19 | |
| WETSQLSGLPEFVKI | 66 | Q8TB92 | |
| SKPVNIFWALEDSVL | 536 | Q9P2B2 | |
| KSAILNEWTLTPLAL | 181 | Q9Y4G2 | |
| PQLTLWDVFGANKEV | 376 | Q9HA92 | |
| EGPLLRWLKVNFSEA | 321 | Q8NEY4 | |
| ITLNDVPVWSKLESG | 151 | P62341 | |
| FSEENSPKWRGLLVS | 11 | Q07890 | |
| KQWITLDTGILESPF | 96 | Q9NX52 | |
| LQKDSEGDTPSLINW | 286 | O95425 | |
| QTLTDWLLDAPKLAG | 556 | O43426 | |
| LALAKAWPTVLQTGT | 16 | P31040 | |
| KLALTEWLQEFGVPH | 381 | O60502 | |
| SWLHNDLKVALIGSP | 421 | P28331 | |
| QILPRLGFTDLFSKW | 331 | P29622 | |
| LLKLAEETNIFPTSW | 146 | Q8N565 | |
| KGLLLTASLLNFWNP | 16 | Q9UQ74 | |
| KGLLLTASLLNFWNP | 16 | Q00887 | |
| GLALPEKLFWNTSGL | 166 | Q8IXR5 | |
| VLDALQLPKSWLNGS | 291 | Q96ME1 | |
| LVLRKPGINVASDWS | 926 | Q14697 | |
| NFEETKSLPWILLGA | 186 | P32249 | |
| LTGLILKQDPESAWF | 416 | Q14916 | |
| EDTGWLLFPVNKAAR | 2076 | P58107 | |
| SVLPGSKLVDWLLAQ | 541 | Q8TCU6 | |
| PSSTFFQAELWIKEL | 331 | Q9P0U3 | |
| SLLEKTWLGAPIQFA | 6 | Q8NEZ3 | |
| GLSPLLQKITDWDSS | 511 | Q8WU76 | |
| VGQPVFLSQFKLLWS | 41 | Q9BUU2 | |
| KGLLLTASLLNFWNP | 16 | Q13046 | |
| WTTVGPELNGLDSKL | 1246 | Q7RTU9 | |
| NTWGDFLEAILPLAV | 426 | Q9H6W3 | |
| GITIAWKFDSPERNL | 626 | P42229 | |
| ALPLWKVTAFIGNSI | 26 | O95484 | |
| NLPTLQDSGIKWSER | 71 | O95436 | |
| LWQTLDLTGKNLHPD | 136 | Q13309 | |
| FQTLLNTIPGWLISE | 2801 | A4UGR9 | |
| SEPLAGKWFSQLTLG | 121 | Q6SA08 | |
| SEKEQGPEFWGLSLI | 266 | P17040 | |
| PIVWQGLLALKNDTA | 3506 | Q96T58 | |
| LVSQSGFWAKALPEE | 146 | O76050 | |
| GAPGIKQDLDAVTLW | 121 | Q92504 | |
| LWGLPSVVQKSQEDF | 636 | Q6ZQQ2 | |
| LDILKDNWSPALTIS | 146 | Q969T4 | |
| AQLEEWALKGISRPS | 26 | Q6NX45 | |
| PGWKNLTVILSDASA | 186 | Q9H0D6 | |
| LIGPAKIFSSVQWLS | 266 | Q9C0C9 | |
| AIADALGKIPQTVLW | 321 | P22309 | |
| PEGVWSERKFSLLQT | 176 | P78562 | |
| AATFALPWSLTKDGL | 211 | Q9NZC7 | |
| LPWSLTKDGLETTFQ | 216 | Q9NZC7 | |
| GIALPAWIVDQKNSI | 176 | Q9UGP8 | |
| EKSFWLSQSNIPALI | 1046 | Q8WWQ8 | |
| SGWKARTPLEQEIFN | 176 | Q9BVJ6 | |
| ILPTGANKTWGRFEL | 61 | Q5SRD1 | |
| FILQSALNDLWSIKP | 566 | Q86WI1 | |
| KPNLETFTLNWDGIA | 631 | Q86WI1 | |
| TFTLNWDGIASKPLT | 636 | Q86WI1 | |
| SGPKSDVWSLGIILF | 181 | Q8TEA7 | |
| TASLWLGPGIAQKIT | 11 | A0A0A6YYC5 | |
| FATKASPTGVILDLW | 896 | Q8IZJ1 | |
| LITTIASKGELQNWP | 121 | Q92973 | |
| PSSWVGCKLSLVFLQ | 196 | P41587 | |
| FGIDPIWNIATNKLT | 516 | Q93050 | |
| LGLWLETVNDKSGPL | 46 | Q96K49 | |
| GIDPIWNLASNKLTF | 521 | Q9HBG4 | |
| IESFLKERQGALAPW | 411 | Q9H330 | |
| LKPSDLQLSLWGGDV | 21 | Q7Z7G8 | |
| KSLVITAGPWTNQLL | 196 | Q9P0Z9 | |
| FLSWKLEETLAQFPL | 766 | Q96Q05 | |
| IQSLLTNWKGPDLTS | 306 | Q9ULL1 | |
| GAQWSILRKDIPSFE | 151 | P48556 | |
| LQAWKSPGADLLQVL | 506 | Q3LXA3 | |
| PSLGKNTESLGELWL | 1176 | Q5TAX3 | |
| RKWQLGVAFLPASIS | 326 | Q05940 | |
| LEQFLTVLPGELQSW | 91 | O95125 | |
| LIFVKSWNTEAGVPL | 96 | Q08AF3 | |
| IPVSEQHWIGFLSLK | 91 | Q06418 | |
| LWVKTLQPDGGSNLL | 236 | A6NCI4 | |
| LTIEFPNLDKTSAEW | 396 | A6NCI4 | |
| LLPAVDFSLGEWKTQ | 61 | P40225 | |
| VLALPGFVWKQLSGE | 616 | Q5T447 | |
| ESPAGLAIDWVTNKL | 816 | O75096 | |
| LFLGNSAKPVWRLET | 156 | B1AL88 | |
| LAKETLEPLSQAAWL | 1626 | Q9NQX4 | |
| GADLLESFAVPNLWK | 156 | Q9HAN9 |